Level C· Early human research exploring benefitsCohort StudyEurope PMCOpen access

The Goto-Kakizaki rat is a spontaneous prototypical rodent model of polycystic ovary syndrome

Bourgneuf C., Bailbé D., Lamazière A., Dupont C., Moldes M., Farabos D.

Cohort Study on Type 2 Diabetes, published in Nat Commun (2021) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Cohort Study
Journal
Nat Commun (2021)
Reported sample size
—
Source database
Europe PMC
PMID
33594056
PMCID
PMC7886868
DOI
10.1038/s41467-021-21308-y
Citations
34

Abstract (original English)

Polycystic ovary syndrome (PCOS) is characterized by an oligo-anovulation, hyperandrogenism and polycystic ovarian morphology combined with major metabolic disturbances. However, despite the high prevalence and the human and economic consequences of this syndrome, its etiology remains unknown. In this study, we show that female Goto-Kakizaki (GK) rats, a type 2 diabetes mellitus model, encapsulate naturally all the reproductive and metabolic hallmarks of lean women with PCOS at puberty and in adulthood. The analysis of their gestation and of their fetuses demonstrates that this PCOS-like phenotype is developmentally programmed. GK rats also develop features of ovarian hyperstimulation syndrome. Lastly, a comparison between GK rats and a cohort of women with PCOS reveals a similar reproductive signature. Thus, this spontaneous rodent model of PCOS represents an original tool for the identification of the mechanisms involved in its pathogenesis and for the development of novel strategies for its treatment.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
OvaryEndocrine SystemAnimalsAnimals, NewbornHumansRatsRats, WistarPolycystic Ovary SyndromeDisease Models, AnimalBody Weight

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research